eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
8/2006
vol. 10
 
Share:
Share:
abstract:

Allogeneic haematopoietic stem cell transplantation: results of the procedure in The Lower Silesian Center of Cellular Transplantation with National Bone Marrow Donors Registry

Andrzej Lange
,
Mariola Sędzimirska

Współcz Onkol (2006) vol. 10; 8 (391–394)
Online publish date: 2006/10/16
View full text Get citation
 
HSCT from an allogeneic donor is a life-saving procedure in some inborn errors and blood cancers. Analysis of survival curves of 353 patients, among them 280 with leukaemia and lymphomas, shows: (1) in general 50% of patients with blood cancers enjoy 5-year survival, (2) a plateau is reached after 5 years, (3) stage of disease at transplantation affects outcome, (4) survival of pts receiving transplant from unrelated or haploidentical donors is fairly inferior as compared to sibling transplantation and (5) survival rate of pts receiving transplant in last 10 years is superior to that in pts transplanted in years 1889-1996.
keywords:

HSCT, blood cancers, survival curves

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.